Vitamin A Shows Promise as Weight Loss Aid

Tuesday, 17 Jun 2014 05:06 PM

By Nick Tate

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
Researchers at the University of Montreal have determined a derivative of vitamin A holds promise as a potential obesity treatment and may help stave off Type 2 diabetes and cardiovascular problems.
 
In a new study of mice — presented this month at a meeting of the Canadian Nutrition Society in Saint John's, Newfoundland — UM researchers reported retinoic acid (RA) has been found to offer protection against obesity-related metabolic and cardiac conditions.
 
"Blood glucose, insulin resistance [and] body weight … were significantly decreased in treated animals, including abdominal fat, while dietary intake and physical activity were similar for treated or non-treated animals," said lead researcher Daniel-Constantin Manolescu.
 
The researchers said retinoic acid helps to normalize blood sugar and combat obesity by boosting metabolism, which burns energy and calories.

Special: These 5 Things Flush 40 lbs. of Fat Out of Your Body.
 
"Our research identifies new metabolic effects of retinoids and may lead to anti-obesity and anti-diabetic medicines," said co-researcher Dr. Jean-Louis Chiasson.

© 2014 NewsmaxHealth. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

New Fertility Treatment Cheaper, Effective

Wednesday, 22 Oct 2014 08:36 AM

A crucial part of conventional in vitro fertilization (IVF) -- the incubation of embryos in a laboratory dish -- can ins . . .

'Breakthrough' Peanut Allergy Treatment Hits Market

Wednesday, 22 Oct 2014 08:20 AM

French biotechfirm DBV Technologies - developer of what it says is a breakthrough treatment for peanut allergy sufferers . . .

Drugmakers to Join Forces to Make Millions of Ebola Vaccine Doses

Wednesday, 22 Oct 2014 08:11 AM

J J has simplified and fast-tracked its vaccine program in the light of the world's worst Ebola outbreak.
Leading d . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved